Amy L. Cole
Amy L. Cole
Associate Professor, University of Central Florida
Verified email at ucf.edu
TitleCited byYear
Cutting edge: IFN-inducible ELR− CXC chemokines display defensin-like antimicrobial activity
AM Cole, T Ganz, AM Liese, MD Burdick, L Liu, RM Strieter
The Journal of Immunology 167 (2), 623-627, 2001
3902001
Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2
KA Walton, AL Cole, M Yeh, G Subbanagounder, SR Krutzik, RL Modlin, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (7), 1197-1203, 2003
1952003
Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8 A ROLE FOR TOLL-LIKE RECEPTOR 4 AND A …
KA Walton, X Hsieh, N Gharavi, S Wang, G Wang, M Yeh, AL Cole, ...
Journal of Biological Chemistry 278 (32), 29661-29666, 2003
1702003
Field production and functional evaluation of chloroplast‐derived interferon‐α2b
PA Arlen, R Falconer, S Cherukumilli, A Cole, AM Cole, KK Oishi, ...
Plant biotechnology journal 5 (4), 511-525, 2007
1672007
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid
N Venkataraman, AL Cole, P Svoboda, J Pohl, AM Cole
The Journal of Immunology 175 (11), 7560-7567, 2005
1672005
Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway
AL Cole, G Subbanagounder, S Mukhopadhyay, JA Berliner, DK Vora
Arteriosclerosis, thrombosis, and vascular biology 23 (8), 1384-1390, 2003
1312003
Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT) 3 pathway
M Yeh, NM Gharavi, J Choi, X Hsieh, E Reed, KP Mouillesseaux, AL Cole, ...
Journal of Biological Chemistry 279 (29), 30175-30181, 2004
1252004
Antimicrobial polypeptides are key anti‐HIV‐1 effector molecules of cervicovaginal host defense
AM Cole, AL Cole
American journal of reproductive immunology 59 (1), 27-34, 2008
1212008
PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity
MJ Keller, E Guzman, E Hazrati, A Kasowitz, N Cheshenko, S Wallenstein, ...
Aids 21 (4), 467-476, 2007
1132007
Reawakening retrocyclins: ancestral human defensins active against HIV-1
N Venkataraman, AL Cole, P Ruchala, AJ Waring, RI Lehrer, O Stuchlik, ...
PLoS biology 7 (4), e1000095, 2009
972009
Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products
M Yeh, AL Cole, J Choi, Y Liu, D Tulchinsky, JH Qiao, MC Fishbein, ...
Circulation research 95 (8), 780-788, 2004
932004
Exoproteome of Staphylococcus aureus Reveals Putative Determinants of Nasal Carriage
G Muthukrishnan, GA Quinn, RP Lamers, C Diaz, AL Cole, S Chen, ...
Journal of proteome research 10 (4), 2064-2078, 2011
702011
The role of human innate immune factors in nasal colonization by Staphylococcus aureus
A van Belkum, M Emonts, H Wertheim, C de Jongh, J Nouwen, H Bartels, ...
Microbes and infection 9 (12-13), 1471-1477, 2007
672007
Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma
JA Martellini, AL Cole, N Venkataraman, GA Quinn, P Svoboda, ...
The FASEB Journal 23 (10), 3609-3618, 2009
652009
The retrocyclin analogue RC‐101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct
AL Cole, A Herasimtschuk, P Gupta, AJ Waring, RI Lehrer, AM Cole
Immunology 121 (1), 140-145, 2007
512007
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques
AM Cole, DL Patton, LC Rohan, AL Cole, Y Cosgrove-Sweeney, ...
PLoS One 5 (11), e15111, 2010
492010
Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay
CR Eade, C Diaz, MP Wood, K Anastos, BK Patterson, P Gupta, AL Cole, ...
PLoS One 7 (11), e50106, 2012
462012
HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41
AL Cole, OO Yang, AD Warren, AJ Waring, RI Lehrer, AM Cole
The Journal of Immunology 176 (11), 6900-6905, 2006
462006
Retrocyclins and their activity against HIV-1
WT Penberthy, S Chari, AL Cole, AM Cole
Cellular and Molecular Life Sciences 68 (13), 2231-2242, 2011
452011
Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product
AB Sassi, MR Cost, AL Cole, AM Cole, DL Patton, P Gupta, LC Rohan
Antimicrobial agents and chemotherapy 55 (5), 2282-2289, 2011
442011
The system can't perform the operation now. Try again later.
Articles 1–20